Prilenia Plans To Continue With Pridopidine In ALS Despite Platform Study Miss

 
• By Joseph Haas
  
Neurodegeneration
Prilenia still hopes to advance pridopidine in ALS • Source: Shutterstock

More from Clinical Trials

More from R&D